Gene therapy combined with IMRT found to reduce recurrence for select prostate cancer patients

(American Society for Radiation Oncology) Combining oncolytic adenovirus-mediated cytotoxic gene therapy with intensity modulated radiation therapy reduces the risk of having a positive prostate biopsy two years after treatment in intermediate-risk prostate cancer without affecting patients' quality of life.